GB8807803D0 - Biochemical product - Google Patents

Biochemical product

Info

Publication number
GB8807803D0
GB8807803D0 GB888807803A GB8807803A GB8807803D0 GB 8807803 D0 GB8807803 D0 GB 8807803D0 GB 888807803 A GB888807803 A GB 888807803A GB 8807803 A GB8807803 A GB 8807803A GB 8807803 D0 GB8807803 D0 GB 8807803D0
Authority
GB
United Kingdom
Prior art keywords
biochemical product
biochemical
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB888807803A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB888807803A priority Critical patent/GB8807803D0/en
Publication of GB8807803D0 publication Critical patent/GB8807803D0/en
Priority to IL89804A priority patent/IL89804A0/xx
Priority to GB8907148A priority patent/GB2218101A/en
Priority to NL8900779A priority patent/NL8900779A/nl
Priority to DE3910323A priority patent/DE3910323A1/de
Priority to KR1019890004087A priority patent/KR890014125A/ko
Priority to BE8900350A priority patent/BE1001845A4/fr
Priority to SE8901115A priority patent/SE8901115L/sv
Priority to IT8947794A priority patent/IT1232827B/it
Priority to DK156589A priority patent/DK156589A/da
Priority to AU32287/89A priority patent/AU3228789A/en
Priority to FR8904160A priority patent/FR2629345A1/fr
Priority to JP1076871A priority patent/JPH02117700A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GB888807803A 1988-03-31 1988-03-31 Biochemical product Pending GB8807803D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GB888807803A GB8807803D0 (en) 1988-03-31 1988-03-31 Biochemical product
JP1076871A JPH02117700A (ja) 1988-03-31 1989-03-30 生物学的に活性な蛋白質
BE8900350A BE1001845A4 (fr) 1988-03-31 1989-03-30 Proteines qui inhibent l'activite due au facteur de necrose tumorale.
GB8907148A GB2218101A (en) 1988-03-31 1989-03-30 TNF-alpha inhibitors
NL8900779A NL8900779A (nl) 1988-03-31 1989-03-30 Eiwit dat de werking van tumor necrose factor tegengaat, dna dat voor zulk eiwit codeert, een vector die zulk dna bevat, een met die vector getransformeerde gastheercel en een farmaceutisch preparaat dat dat eiwit bevat.
DE3910323A DE3910323A1 (de) 1988-03-31 1989-03-30 Biologisch aktive proteine
KR1019890004087A KR890014125A (ko) 1988-03-31 1989-03-30 생물학적으로 활성인 단백질
IL89804A IL89804A0 (en) 1988-03-31 1989-03-30 Biologically active proteins
SE8901115A SE8901115L (sv) 1988-03-31 1989-03-30 Biologiskt aktiva proteiner
IT8947794A IT1232827B (it) 1988-03-31 1989-03-30 Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
DK156589A DK156589A (da) 1988-03-31 1989-03-30 Protein der inhiberer en tumornekrosefaktoraktivitet
AU32287/89A AU3228789A (en) 1988-03-31 1989-03-30 Biologically active proteins
FR8904160A FR2629345A1 (fr) 1988-03-31 1989-03-30 Proteines qui inhibent l'activite due au facteur de necrose tumorale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888807803A GB8807803D0 (en) 1988-03-31 1988-03-31 Biochemical product

Publications (1)

Publication Number Publication Date
GB8807803D0 true GB8807803D0 (en) 1988-05-05

Family

ID=10634493

Family Applications (2)

Application Number Title Priority Date Filing Date
GB888807803A Pending GB8807803D0 (en) 1988-03-31 1988-03-31 Biochemical product
GB8907148A Withdrawn GB2218101A (en) 1988-03-31 1989-03-30 TNF-alpha inhibitors

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB8907148A Withdrawn GB2218101A (en) 1988-03-31 1989-03-30 TNF-alpha inhibitors

Country Status (12)

Country Link
JP (1) JPH02117700A (sv)
KR (1) KR890014125A (sv)
AU (1) AU3228789A (sv)
BE (1) BE1001845A4 (sv)
DE (1) DE3910323A1 (sv)
DK (1) DK156589A (sv)
FR (1) FR2629345A1 (sv)
GB (2) GB8807803D0 (sv)
IL (1) IL89804A0 (sv)
IT (1) IT1232827B (sv)
NL (1) NL8900779A (sv)
SE (1) SE8901115L (sv)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83878A (en) * 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
US5811261A (en) * 1988-09-12 1998-09-22 Yeda Research And Development Co. Ltd. Expression of the recombinant tumor necrosis factor binding protein I (TBP-I)
US7264944B1 (en) 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
EP0393438B1 (de) * 1989-04-21 2005-02-16 Amgen Inc. TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs
US6221675B1 (en) 1989-04-21 2001-04-24 Amgen, Inc. TNF receptors, TNF binding proteins and DNAs coding for them
IL95031A (en) * 1989-07-18 2007-03-08 Amgen Inc A method of producing a recombinant human necrotic factor absorber
US6143866A (en) * 1989-07-18 2000-11-07 Amgen, Inc. Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
US5945397A (en) * 1989-09-05 1999-08-31 Immunex Corporation Purified p75 (type II) tumor necrosis factor receptor polypeptides
US5605690A (en) * 1989-09-05 1997-02-25 Immunex Corporation Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
CA2485553A1 (en) * 1989-09-05 1991-03-21 Immunex Corporation Tumor necrosis factor - .alpha. and - .beta. receptors
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
EP0417563B1 (de) * 1989-09-12 2000-07-05 F. Hoffmann-La Roche Ag TNF-bindende Proteine
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
WO1992001002A1 (fr) * 1990-07-11 1992-01-23 Teijin Limited Inhibiteur de l'activite du facteur de la necrose tumorale et son procede de preparation
US5304634A (en) * 1990-10-12 1994-04-19 Hoechst Aktiengesellschaft Inhibitors for the formation of tumor necrosis factor
WO1992013095A1 (en) * 1991-01-18 1992-08-06 Synergen, Inc. Methods for treating tumor necrosis factor mediated diseases
WO1993004375A1 (en) * 1991-08-23 1993-03-04 Nchip, Inc. Burn-in technologies for unpackaged integrated circuits
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
AU5696198A (en) 1996-12-06 1998-06-29 Amgen, Inc. Combination therapy using a tnf binding protein for treating tnf-mediated diseases
WO1998024477A1 (en) 1996-12-06 1998-06-11 Amgen Inc. Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
DK2295081T3 (en) 2001-06-26 2019-02-18 Amgen Inc Antibodies to OPGL
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
WO2004060911A2 (en) 2002-12-30 2004-07-22 Amgen Inc. Combination therapy with co-stimulatory factors
US7833527B2 (en) 2006-10-02 2010-11-16 Amgen Inc. Methods of treating psoriasis using IL-17 Receptor A antibodies
TW201117824A (en) 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
HUE035618T2 (en) 2010-01-15 2018-05-28 Kirin Amgen Inc Antibody presentation and therapeutic regimens
US20140234330A1 (en) 2011-07-22 2014-08-21 Amgen Inc. Il-17 receptor a is required for il-17c biology
CA2944605C (en) 2014-03-31 2023-10-17 Kirin-Amgen, Inc. Methods of treating nail and scalp psoriasis

Also Published As

Publication number Publication date
KR890014125A (ko) 1989-10-21
FR2629345A1 (fr) 1989-10-06
SE8901115L (sv) 1989-10-01
SE8901115D0 (sv) 1989-03-30
DK156589D0 (da) 1989-03-30
BE1001845A4 (fr) 1990-03-20
NL8900779A (nl) 1989-10-16
GB2218101A (en) 1989-11-08
DE3910323A1 (de) 1989-10-19
IL89804A0 (en) 1989-09-28
IT1232827B (it) 1992-03-05
JPH02117700A (ja) 1990-05-02
AU3228789A (en) 1989-10-05
IT8947794A0 (it) 1989-03-30
DK156589A (da) 1989-10-01
GB8907148D0 (en) 1989-05-10

Similar Documents

Publication Publication Date Title
GB8807803D0 (en) Biochemical product
HUT44919A (en) Cigarettelike product
GB2223027B (en) Periodontium-regenerative materials
GB8827986D0 (en) Chemical product
GB2217679B (en) Plastics can
GB2225275B (en) Slate-filled resin products
GB2239601B (en) Odontotherapeutical materials
GB8809440D0 (en) Aniline-resorcin-formaldehyde copoly-condensation product
IL92508A0 (en) Novel alpha-cyano-beta-oxopropionamides
GB2257891B (en) Pre-dusting protein products
GB8820375D0 (en) Assay
GB8814340D0 (en) Process
GB8829642D0 (en) Products
GB8802484D0 (en) Process
GB8807802D0 (en) Biochemical product
GB8813486D0 (en) Product
IE880321L (en) Probiotic-type product
GB8828513D0 (en) Novel products
IE880421L (en) Silicate-resin products
GB8822127D0 (en) Clay products
GB8800312D0 (en) Process
GB8901432D0 (en) Product
IE892701L (en) Medianal products
GB8903970D0 (en) Biological product
GB8723201D0 (en) Product